Moscow [Russia], January 18 (ANI/Sputnik): The effectiveness of the Sputnik V COVID-19 vaccine against the Omicron coronavirus variant is 75 per cent, Alexander Gintsburg, the head of Russia's Gamaleya Research Center, said on Tuesday.
Moscow [Russia], December 13 (ANI/Sputnik): The Omicron strain of the coronavirus could eventually replace the Delta variant, as it is already happening in South Africa, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.
Moscow [Russia], December 11 (ANI/Sputnik): Patients infected with the Omicron variant of COVID-19, who arrived in Russia from South Africa, were earlier vaccinated, their disease is mild, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Micr
Moscow [Russia], March 14 (ANI/Sputnik): The Russian-made Sputnik V coronavirus vaccine has proven equally effective for all age groups, Alexander Gintsburg, the head of the Gamaleya research institute that developed the vaccine, said on Saturday.
Moscow [Russia], July 18 (Sputnik/ ANI): Russia's Gamaleya Institute of Epidemiology and Microbiology has produced a coronavirus vaccine that is patented and more advanced than Western competitors and will be happy to share the technology with foreign colleagues, should they require, the ins